Norges Bank’s Bicara Therapeutics BCAX Stock Holding History
Bought
Maintained
Sold
Other funds holding BCAX
SL
Norges Bank's BCAX Position: Q2 2026 in Review
Norges Bank sold out of Bicara Therapeutics (BCAX) in Q2 2026, closing a stake of 42,889 shares — an estimated $722K sold.
Norges Bank first reported a position in BCAX in Q3 2024 and held it in 6 quarters. The position peaked at $1.78M in Q3 2024. 171 funds tracked by Wall St. Rank hold BCAX as of Q2 2026.
- Norges Bank reported no remaining Bicara Therapeutics position as of Q2 2026 after selling out during the quarter.
- Norges Bank sold 42,889 Bicara Therapeutics shares in Q2 2026, an estimated $722K.
- Norges Bank first reported a position in Bicara Therapeutics in Q3 2024 and held it in 6 quarters.
- Norges Bank's Bicara Therapeutics position peaked at $1.78M in Q3 2024.
- 171 funds tracked by Wall St. Rank held Bicara Therapeutics as of Q2 2026.
Based on Norges Bank's 13F filing for Q2 2026, filed 12 Aug 2026.